Globocanによると、膀胱がんの世界的な負担は非常に高く、すべての新しいがん診断の3.0％、2020年のすべてのがんによる死亡の2.1％、そして世界で11番目に頻繁に診断されているがんです。したがって、政府当局は膀胱がん検査キットに関連する製品の開発を注視しています。これらの機関は、膀胱がんの早期発見を支援し、病気の負担をさらに軽減する膀胱がん検出キットを製造するためのガイドラインを策定しています。
目次
TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting bladder cancer detection kittype
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Porter’s Five Forces Analysis
5.1.1. Bargaining Power of Suppliers
5.1.2. Bargaining Power of Buyers
5.1.3. Threat of New Entrants
5.1.4. Threat of Substitutes
5.1.5. Intensity of Rivalry
5.2. Value Chain Analysis
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Impact on Supply Chain
5.3.3. Regional Impact
5.3.4. Opportunity and Threat Analysis
6. GLOBAL BLADDER CANCER DETECTION KITMARKET, BY TECHNOLOGY
6.1. Overview
6.2. Fluorescence In Situ Hybridization (FISH)
Market Estimates & Forecast, by Region, 2018-2027
Market Estimates & Forecast, by Country, 2018-2027
6.3. Enzyme-Linked Immunosorbent Assay (ELISA)
Market Estimates & Forecast, by Region, 2018-2027
Market Estimates & Forecast, by Country, 2018-2027
6.4. Others
Market Estimates & Forecast, by Region, 2018-2027
Market Estimates & Forecast, by Country, 2018-2027
7. GLOBAL BLADDER CANCER DETECTION KITMARKET, BY END USER
7.1. Overview
7.2. Hospitals & Clinics
Market Estimates & Forecast, by Region, 2018-2027
Market Estimates & Forecast, by Country, 2018-2027
7.3. Diagnostic Centers
Market Estimates & Forecast, by Region, 2018-2027
Market Estimates & Forecast, by Country, 2018-2027
7.4. Others
Market Estimates & Forecast, by Region, 2018-2027
Market Estimates & Forecast, by Country, 2018-2027
8. GLOBAL BLADDER CANCER DETECTION KITMARKET, BY REGION
8.1. Overview
8.2. North America
8.2.1. US
8.2.2. Canada
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. Italy
8.3.4. Spain
8.3.5. UK
8.3.6. Rest of Europe
8.4. Asia-Pacific
8.4.1. Japan
8.4.2. China
8.4.3. India
8.4.4. Australia
8.4.5. South Korea
8.4.6. Rest of Asia-Pacific
8.5. Rest of the World
8.5.1. Middle East
8.5.2. Africa
8.5.3. Latin America
9. COMPANY LANDSCAPE
9.1. Overview
9.2. Competitive Analysis
9.3. Market Share Analysis
9.4. Major Growth Strategy in the Global Bladder Cancer Detection Kit Market
9.5. Competitive Benchmarking
9.6. Leading Players in Terms of the Number of Developments in the Global Bladder Cancer Detection Kit Market
9.7. Key developments and Growth Strategies
9.7.1. New ProductLaunch/Service Deployment
9.7.2. Merger &Acquisitions
9.7.3. Joint Ventures
9.8. Major Players Financial Matrix
9.8.1. Sales & Operating Income, 2020
9.8.2. Major Players R&D Expenditure, 2020
10. COMPANY PROFILES
10.1. Abbott Laboratories
10.1.1. Company Overview
10.1.2. Product Offered
10.1.3. Financial Overview
10.1.4. Key Developments
10.1.5. SWOT Analysis
10.1.6. Key Strategies
10.2. Xiamen Biotime Biotechnology
10.2.1. Company Overview
10.2.2. Products Offered
10.2.3. Financial Overview
10.2.4. Key Developments
10.2.5. SWOT Analysis
10.2.6. Key Strategies
10.3. Exact Sciences
10.3.1. Company Overview
10.3.2. Products Offered
10.3.3. Financial Overview
10.3.4. Key Developments
10.3.5. SWOT Analysis
10.3.6. Key Strategies
10.4. Hubei Jinjian Biology
10.4.1. Company Overview
10.4.2. Products Offered
10.4.3. Financial Overview
10.4.4. Key Developments
10.4.5. SWOT Analysis
10.4.6. Key Strategies
10.5. Nanjing Liming Bio-products Co., Ltd
10.5.1. Company Overview
10.5.2. Products Offered
10.5.3. Financial Overview
10.5.4. Key Developments
10.5.5. SWOT Analysis
10.5.6. Key Strategies
10.6. Abingdon Health
10.6.1. Company Overview
10.6.2. Products Offered
10.6.3. Financial Overview
10.6.4. Key Developments
10.6.5. SWOT Analysis
10.6.6. Key Strategies
10.7. Ameritek, Inc.
10.7.1. Company Overview
10.7.2. Products Offered
10.7.3. Financial Overview
10.7.4. Key Developments
10.7.5. SWOT Analysis
10.7.6. Key Strategies
10.8. Alfa Scientific Designs
10.8.1. Company Overview
10.8.2. Products Offered
10.8.3. Financial Overview
10.8.4. Key Developments
10.8.5. SWOT Analysis
10.8.6. Key Strategies
10.9. NanoEnTek Inc.
10.9.1. Company Overview
10.9.2. Products Offered
10.9.3. Financial Overview
10.9.4. Key Developments
10.9.5. SWOT Analysis
10.9.6. Key Strategies
10.10. Diagnosis S.A.
10.10.1. Company Overview
10.10.2. Products Offered
10.10.3. Financial Overview
10.10.4. Key Developments
10.10.5. SWOT Analysis
10.10.6. Key Strategies
10.11. Xiamen Boson Biotech Co., Ltd
10.11.1. Company Overview
10.11.2. Products Offered
10.11.3. Financial Overview
10.11.4. Key Developments
10.11.5. SWOT Analysis
10.11.6. Key Strategies
11. APPENDIX
11.1. References
11.2. Related Reports
?
LIST OF TABLES
TABLE 1 GLOBAL BLADDER CANCER DETECTION KITMARKET SYNOPSIS, 2018-2027
TABLE 2 GLOBAL BLADDER CANCER DETECTION KITMARKET ESTIMATES &FORECAST, 2018-2027 (USD MILLION)
TABLE 3 GLOBAL BLADDER CANCER DETECTION KITMARKET, BY TECHNOLOGY, 2018-2027 (USD MILLION)
TABLE 4 GLOBAL BLADDER CANCER DETECTION KITMARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 5 NORTH AMERICA: BLADDER CANCER DETECTION KITMARKET, BY TECHNOLOGY, 2018-2027 (USD MILLION)
TABLE 6 NORTH AMERICA: BLADDER CANCER DETECTION KITMARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 7 US: BLADDER CANCER DETECTION KITMARKET, BY TECHNOLOGY, 2018-2027 (USD MILLION)
TABLE 8 US: BLADDER CANCER DETECTION KITMARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 9 CANADA: BLADDER CANCER DETECTION KITMARKET, BY TECHNOLOGY, 2018-2027 (USD MILLION)
TABLE 10 CANADA: BLADDER CANCER DETECTION KITMARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 11 EUROPE: BLADDER CANCER DETECTION KITMARKET, BY TECHNOLOGY, 2018-2027 (USD MILLION)
TABLE 12 EUROPE: BLADDER CANCER DETECTION KITMARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 13 GERMANY: BLADDER CANCER DETECTION KITMARKET, BY TECHNOLOGY, 2018-2027 (USD MILLION)
TABLE 14 GERMANY: BLADDER CANCER DETECTION KITMARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 15 FRANCE: BLADDER CANCER DETECTION KIT MARKET, BY TECHNOLOGY, 2018-2027 (USD MILLION)
TABLE 16 FRANCE: BLADDER CANCER DETECTION KIT MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 17 ITALY: BLADDER CANCER DETECTION KITMARKET, BY TECHNOLOGY, 2018-2027 (USD MILLION)
TABLE 18 ITALY: BLADDER CANCER DETECTION KITMARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 19 SPAIN: BLADDER CANCER DETECTION KITMARKET, BY TECHNOLOGY, 2018-2027 (USD MILLION)
TABLE 20 SPAIN: BLADDER CANCER DETECTION KITMARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 21 UK: BLADDER CANCER DETECTION KITMARKET, BY TECHNOLOGY, 2018-2027 (USD MILLION)
TABLE 22 UK: BLADDER CANCER DETECTION KITMARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 23 REST OF EUROPE: BLADDER CANCER DETECTION KITMARKET, BY TECHNOLOGY, 2018-2027 (USD MILLION)
TABLE 24 REST OF EUROPE: BLADDER CANCER DETECTION KITMARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 25 ASIA-PACIFIC: BLADDER CANCER DETECTION KITMARKET, BY TECHNOLOGY, 2018-2027 (USD MILLION)
TABLE 26 ASIA-PACIFIC: BLADDER CANCER DETECTION KITMARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 27 JAPAN: BLADDER CANCER DETECTION KITMARKET, BY TECHNOLOGY, 2018-2027 (USD MILLION)
TABLE 28 JAPAN: BLADDER CANCER DETECTION KITMARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 29 CHINA: BLADDER CANCER DETECTION KITMARKET, BY TECHNOLOGY, 2018-2027 (USD MILLION)
TABLE 30 CHINA: BLADDER CANCER DETECTION KITMARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 31 INDIA: BLADDER CANCER DETECTION KITMARKET, BY TECHNOLOGY, 2018-2027 (USD MILLION)
TABLE 32 INDIA: BLADDER CANCER DETECTION KITMARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 33 AUSTRALIA: BLADDER CANCER DETECTION KITMARKET, BY TECHNOLOGY, 2018-2027 (USD MILLION)
TABLE 34 AUSTRALIA: BLADDER CANCER DETECTION KITMARKET, END USER, 2018-2027 (USD MILLION)
TABLE 35 SOUTH KOREA: BLADDER CANCER DETECTION KITMARKET, BY TECHNOLOGY, 2018-2027 (USD MILLION)
TABLE 36 SOUTH KOREA: BLADDER CANCER DETECTION KITMARKET, END USER, 2018-2027 (USD MILLION)
TABLE 37 REST OF ASIA-PACIFIC: BLADDER CANCER DETECTION KITMARKET, BY TECHNOLOGY, 2018-2027 (USD MILLION)
TABLE 38 REST OF ASIA-PACIFIC: BLADDER CANCER DETECTION KITMARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 39 REST OF THE WORLD: BLADDER CANCER DETECTION KITMARKET, BY TECHNOLOGY, 2018-2027 (USD MILLION)
TABLE 40 REST OF THE WORLD: BLADDER CANCER DETECTION KITMARKET, END USER, 2018-2027 (USD MILLION)
TABLE 41 MIDDLE EAST: BLADDER CANCER DETECTION KITMARKET, BY TECHNOLOGY, 2018-2027 (USD MILLION)
TABLE 42 MIDDLE EAST: BLADDER CANCER DETECTION KITMARKET, END USER, 2018-2027 (USD MILLION)
TABLE 43 AFRICA: BLADDER CANCER DETECTION KITMARKET, BY TECHNOLOGY, 2018-2027 (USD MILLION)
TABLE 44 AFRICA: BLADDER CANCER DETECTION KITMARKET, END USER, 2018-2027 (USD MILLION)
TABLE 45 LATIN AMERICA: BLADDER CANCER DETECTION KITMARKET, BY TECHNOLOGY, 2018-2027 (USD MILLION)
TABLE 46 LATIN AMERICA: BLADDER CANCER DETECTION KITMARKET, END USER, 2018-2027 (USD MILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL BLADDER CANCER DETECTION KITMARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL BLADDER CANCER DETECTION KITMARKET
FIGURE 4 GLOBAL BLADDER CANCER DETECTION KITMARKET SHARE, BY TECHNOLOGY, 2020 (%)
FIGURE 5 GLOBAL BLADDER CANCER DETECTION KITMARKET SHARE, BY END USER, 2020(%)
FIGURE 6 GLOBAL BLADDER CANCER DETECTION KITMARKET SHARE, BY REGION, 2020(%)
FIGURE 7 NORTH AMERICA: BLADDER CANCER DETECTION KITMARKET SHARE, BY REGION, 2020(%)
FIGURE 8 EUROPE: BLADDER CANCER DETECTION KITMARKET SHARE, BY REGION, 2020(%)
FIGURE 9 ASIA-PACIFIC: BLADDER CANCER DETECTION KITMARKET SHARE, BY REGION, 2020(%)
FIGURE 10 REST OF THE WORLD: BLADDER CANCER DETECTION KITMARKET SHARE, BY REGION, 2020(%)
FIGURE 11 GLOBAL BLADDER CANCER DETECTION KITMARKET: COMPANY SHARE ANALYSIS, 2020(%)
FIGURE 12 ABBOTT LABORATORIES: FINANANCIAL OVERVIEW SNAPSHOT
FIGURE 13 ABBOTT LABORATORIES: SWOT ANALYSIS
FIGURE 14 XIAMEN BIOTIME BIOTECHNOLOGY:FINANANCIAL OVERVIEW SNAPSHOT
FIGURE 15 XIAMEN BIOTIME BIOTECHNOLOGY:SWOT ANALYSIS
FIGURE 16 EXACT SCIENCES.:FINANANCIAL OVERVIEW SNAPSHOT
FIGURE 17 EXACT SCIENCES:SWOT ANALYSIS
FIGURE 18 EXACT SCIENCES:FINANANCIAL OVERVIEW SNAPSHOT
FIGURE 19 EXACT SCIENCES:SWOT ANALYSIS
FIGURE 20 HUBEI JINJIAN BIOLOGY:FINANANCIAL OVERVIEW SNAPSHOT
FIGURE 21 HUBEI JINJIAN BIOLOGY:SWOT ANALYSIS
FIGURE 22 NANJING LIMING BIO-PRODUCTS CO., LTD:FINANANCIAL OVERVIEW SNAPSHOT
FIGURE 23 NANJING LIMING BIO-PRODUCTS CO., LTD:SWOT ANALYSIS
FIGURE 24 ABINGDON HEALTH:FINANANCIAL OVERVIEW SNAPSHOT
FIGURE 25 ABINGDON HEALTH:SWOT ANALYSIS
FIGURE 26 AMERITEK, INC.: FINANANCIAL OVERVIEW SNAPSHOT
FIGURE 27 AMERITEK, INC.: SWOT ANALYSIS
FIGURE 28 ALFA SCIENTIFIC DESIGNS: FINANANCIAL OVERVIEW SNAPSHOT
FIGURE 29 ALFA SCIENTIFIC DESIGNS: SWOT ANALYSIS
FIGURE 30 NANOENTEK INC.:FINANANCIAL OVERVIEW SNAPSHOT
FIGURE 31 NANOENTEK INC.:SWOT ANALYSIS
FIGURE 32 DIAGNOSIS S.A.:FINANANCIAL OVERVIEW SNAPSHOT
FIGURE 33 DIAGNOSIS S.A.:SWOT ANALYSIS
FIGURE 34 XIAMEN BOSON BIOTECH CO., LTD:FINANANCIAL OVERVIEW SNAPSHOT
FIGURE 35 XIAMEN BOSON BIOTECH CO., LTD:SWOT ANALYSIS
